Clinical trials for cannabis drug
Andrew Bushe
A BRITISH drug firm is carrying out clinical research trials in Ireland to determine the effectiveness of a cannabis extract in controlling severe cancer-related pain.
GW Pharmaceuticals, a market leader in pioneering the use of medicines containing cannabis extract, has received a licence from the Irish Medicines Board under the Control of Clinical Trials Acts 1987 and 1990.
Sativex, which lists a cannabis extract containing THC and cannabidiol as its principal components, is administered using a mouth spray. Regulatory approval is being sought in Britain and Canada.
A BRITISH drug firm is carrying out clinical research trials in Ireland to determine the effectiveness of a cannabis extract in controlling severe cancer-related pain.
GW Pharmaceuticals, a market leader in pioneering the use of medicines containing cannabis extract, has received a licence from the Irish Medicines Board under the Control of Clinical Trials Acts 1987 and 1990.
Sativex, which lists a cannabis extract containing THC and cannabidiol as its principal components, is administered using a mouth spray. Regulatory approval is being sought in Britain and Canada.
posted by Loretta Nall at
7:34 AM
1 Comments:
Medicinal use is good, but unfortunately I feel that making a non-plant, non-recreational version for medicinal use only will only seek to tighten up the laws concerning recreational use whilst satisfying those calling only for medicinal use.
A step backward in my opinion.
By
Unknown, at 1:33 PM
Post a Comment
<< Home